Financials
- Market Capitalization 1.08 B
- Employee 70
- Founded 1995
- CEO N/A
- Website www.savarapharma.com
- Headquarter Delaware, United States
- FIGI BBG000MS0823
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-11.38
ratio cours/chiffre d'affaires
-5 682.19
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2385 | KURA Kura Oncology, Inc. - Common Stock | 12.66 USD | -3.95% | +7.56% | +41.61% | +58.45% | 1.13 B USD | ||
| 2402 | JANX Janux Therapeutics, Inc. - Common Stock | 18.03 USD | -3.99% | +1.86% | +21.17% | -21.13% | 1.10 B USD | ||
| 2424 | AVTX Avalo Therapeutics, Inc. - Common Stock | 19.59 USD | -2.29% | -1.36% | +3.00% | +111.56% | 1.05 B USD | ||
| 2426 | SLDB Solid Biosciences Inc. - Common Stock | 9.77 USD | -3.55% | +5.28% | +20.17% | +71.40% | 1.05 B USD |